לכל הפטריות אישור יבוא של משרד הבריאות.

 תקן GMP  מיוצרים במפעל בקיבוץ מענית, שנמצא בפיקוח משרד הבריאות.

ללא גלוטן.

כשר פרווה.

• 1-2 כמוסות ביום, עד 6 כמוסות ליום
• יש ליטול עם או לאחר הארוחה עם כוס מים
• לנמנעים מבליעה – הקפסולות ניתנות לפתיחה ולשתייה כאבקה

פטריית ההריסיום הינה פטריה בטוחה לשימוש. 

לא ידועה סכנה בשימוש בזמן הריון.

לא ידועה סכנה בשימוש בזמן הנקה.

בכדי לשמור את המוצר טרי ואיכותי, יש לאחסן אותו במקום קריר, יבש ורחוק ממקורות חום, אור ולחות.

קוד הייצור ותאריך התפוגה מוטבעים על גבי האריזה.

בספרות לא קיימות אינטראקציות לשימוש בפטריות, אולם, בשל השפעתן על מערכת החיסון , אין להשתמש בהן למושתלי איברים.

אין לשלב עם תרופות ממשפחת המורפיום. 

המוצר אינו מהווה תחליף לטיפול רפואי או תרופתי. אנשים הנוטלים תרופות מרשם וילדים, יש להיוועץ ברופא.

• I-Chen Li, Li-Ya Lee, Tsai-Teng Tzeng, Wan-Ping Chen, Yen-Po Chen, Young-Ju Shiao,  Chin-Chu Chen. Neurohealth Properties of Hericium erinaceus Mycelia Enriched with Erinacines Behav Neurol. 2018; 2018: 5802634. Published online 2018 May 21. doi: 1155/2018/5802634.
• Liu PS, Chueh SH, Chen CC, Lee LY, Shiu LY. Lion’s Mane Medicinal Mushroom, Hericium erinaceus (Agaricomycetes), Modulates Purinoceptor-Coupled Calcium Signaling and Murine Nociceptive Behavior. Int J Med Mushrooms. 2017;19(6):499-507. Doi: 0.1615/IntJMedMushrooms.v19.i6.20
• Hobbs C. Medicinal Mushrooms, 3rd edn. Santa Cruz: Botanica Press; 1995. 2. Zhou J, Xie G, Yan X. Encyclopedia of Molecular Structures, Pharmacological Activities, Natural Sources and Applications Traditional Chinese Medicines Vol. 5: Isolated Compounds T–Z. Berlin Heidelberg: SpringerVerlag; 2011.
• Kwagishi H, Shimada A, Shirai R, et al. Erinacines A, B and C strong stimulators of nerve growth factor (NGF)- synthesis from the mycelia of Hericium erinaceum. Tetrahedron Lett. 1994;35:1569–72.
• Shen JW, Yu HY, Ruan Y, et al. Hericenones and erinacines: stimulators of nerve growth factor (NGF) biosynthesis in Hericium erinaceus. Mycol Int J Fungal Biol. 210;1:92–8.
• Mizuno T, Wasa T, Ito H, et al. Antitumor-active polysaccharides isolated from the fruiting body of Hericium erinaceum, an edible and medicinal mushroom called Yamabushitake or Houtou. Biosci Biotechnol Biochem. 1992;56:347–8.
• He X, Wang X, Fang J, et al. Structures, biological activities, and industrial applications of the polysaccharides from Hericium erinaceus (Lion’s Mane) mushroom: a review. Int J Biol Macromol. 2017;97:228–37.
• Cheng JH, Tsai CL, Lien YY, et al. High molecular weight of polysaccharides from Hericium erinaceus against amyloid beta-induced neurotoxicity. BMC Complement Altern Med. 2016;16:170.
• Cui F, Gao X, Zhang J, et al. Protective effects of extracellular and intracellular polysaccharides on hepatotoxicity by Hericium erinaceus SG-02. Curr Microbiol. 2016;73(3):379–85.
• Liu J, Du C, Wang Y, Yu Z. Anti-fatigue activities of polysaccharides extracted from Hericium erinaceus. Exp Ther Med. 2015;9(2):483–7.
• Thongbai B, Rapior S, Hyde KD, et al. Hericium erinaceus, an amazing medicinal mushroom. Mycol Progress. 2015;14:91.
• Wang K, Bao L, Qi Q, et al. Erinacerins C-L, isoindolin1-ones with alpha-glucosidase inhibitory activity from cultures of the medicinal mushroom Hericium erinaceus. J Nat Prod. 2015;78(1);146–54.
• Moldavan MG, Gryganski AP, Kolotushkina OV, et al. Neurotropic and trophic action of lion’s mane mushroom Hericium erinaceus (Bull.: Fr.) Pers. (Aphyllophoromycetideae) extracts on nerve cells in vitro. Int J Med Mushrooms. 2007;9:15–28.
• Li JL, Lu L, Dai CC, et al. A comparative study on sterols of ethanol extract and water extract from Hericium erinaceus. Zhongguo Zhong Yao Za Zhi. 2001;26:831−4.
• Abdullah N, Ismail SM, Aminudin N, et al. Evaluation of selected culinary-medicinal mushrooms for antioxidant and ACE inhibitory activities. Evid Based Complement Alternat Med. 2012 (2012), Article ID 464238, 12 pages. http://dx.doi.org/10.1155/2012/464238.
• Gershenzon J, Dudareva N. The function of terpene natural products in the natural world. Nat Chem Biol. 2007;3(7):408–14.
• Chappell J. The genetics and molecular genetics of terpene and sterol origami. Curr Opin Plant Biol. 2002;5(2):151–7.
• Guillamón E, García-Lafuente A, Lozano M, et al. Edible mushrooms: role in the prevention of cardiovascular diseases. Fitoterapia. 2010;81(7):715–23.
• Rahman MA, Abdullah N, Aminudin N. Inhibitory effect on in vitro LDL oxidation and HMG Co-A reductase activity of the liquid-liquid partitioned fractions of Hericium erinaceus (Bull.) Persoon (lion’s mane mushroom). BioMed Res Int. 2014;2014:828149. doi:10.1155/2014/828149.
• Lee KF, Chen JH, Teng CC, et al. Protective effects of Hericium erinaceus mycelium and its isolated erinacine A against ischemia-injury-induced neuronal cell death via the inhibition of iNOS/p38 MAPK and nitrotyrosine. Int J Mol Sci. 2014;15(9):15073–89.
• Yaoita Y, Kakuda R, Machida K, et al. Ceramide constituents from five mushrooms. Chem Pharmaceut Bull. 2002;50(5):551–3.
• Mori K, Obara Y, Hirota M, et al. Nerve growth factor-inducing activity of Hericium erinaceus in 1321N1 human astrocytoma cells. Biol Pharm Bull. 2008;31:1727–32.
• Mori K, Obara Y, Moriya T, et al. Effects of Hericium erinaceus on amyloid beta(25–35) peptide-induced learning and memory deficits in mice. Biomed Res. 2011;32(1):67–72.
• Tzeng TT, Chen CC, Lee LY, et al. Erinacine A-enriched Hericium erinaceus mycelium ameliorates Alzheimer’s disease-related pathologies in APPswe/PS1dE9 transgenic mice. J Biomed Sci. 2016;23:49.
• Trovato A, Siracusa R, Di Paola R, et al. Redox modulation of cellular stress response and lipoxin A4 expression by Hericium erinaceus in rat brain: relevance to Alzheimer’s disease pathogenesis. Immun Ageing. 2016;13:23.
• Zhang J, An S, Hu W, et al. The neuroprotective properties of Hericium erinaceus in glutamate-damaged differentiated PC12 cells and an Alzheimer’s disease mouse model. Int J Mol Sci. 2016;17(11);1810.
• Kuo HC, Lu CC, Shen CH, et al. Hericium erinaceus mycelium and its isolated erinacine A protection from MPTP-induced neurotoxicity through the ER stress, triggering an apoptosis cascade. J Translat Med. 2016;14:78.
• Wong KH, Naidu M, David RP, et al. Neuroregenerative potential of lion’s mane mushroom, Hericium erinaceus (Bull.: Fr.) Pers. (higher Basidiomycetes), in the treatment of peripheral nerve injury (review). Int J Med Mushrooms. 2012;14(5):427–46.
• Mori K, Inatomi S, Ouchi K, et al. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a doubleblind placebo-controlled clinical trial. Phytother Res. 2009;23:367–72.
• Nagano M, Shimizu K, Kondo R, et al. Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake. Biomed Res. 2010;31:231–7.
• Operational guidance: Information needed to support clinical trials of herbal products. http://www.who.int/tdr/ publications/documents/operational-guidance-eng.pdf.
• Lai PL, Naidu M, Sabaratnam V, et al. Neurotrophic properties of the Lion’s mane medicinal mushroom, Hericium erinaceus (Higher Basidiomycetes) from Malaysia. Int J Med Mushrooms. 2013;15(6);539–54.
• Chinese pharmacopoeia. Beijing: Chinese Medicine Science and Technology Publishing House; 2010.
• Wong KH, Naidu M, David P, et al. Peripheral nerve regeneration following crush injury to rat peroneal nerve by aqueous extract of medicinal mushroom Hericium erinaceus (Bull.: Fr) Pers. (Aphyllophoromycetideae). Evid Based Complement Alternat Med. 2011;2011:580752.
• Tanaka A, Matsuda H. Expression of nerve growth factor in itchy skins of atopic NC/NgaTnd mice. J Vet Med Sci. 2005;67:915–9.
• Nakatsugawa M, Takahashi H, Takezawa C, et al. Hericium erinaceum (yamabushitake) extract-induced acute respiratory distress syndrome monitored by serum surfactant proteins. Intern Med. 2003;42:1219–22.
• Kawagishi H., Ando M., Sakamoto H., et al. Hericenones C, D and E, stimulators of nerve growth factor (NGF)-synthesis, from the mushroom Hericium erinaceum. Tetrahedron Letters. 1991;32(35):4561–4564. doi: 10.1016/0040-4039(91)80039-9.
• Kawagishi H., Ando M., Shinba K., et al. Chromans, hericenones F, G and H from the mushroom Hericium erinaceum. Phytochemistry. 1992;32(1):175–178. doi: 10.1016/0031-9422(92)80127-Z.
• Kawagishi H., Shimada A., Shirai R., et al. Erinacines A, B and C, strong stimulators of nerve growth factor (NGF)-synthesis, from the mycelia of Hericium erinaceum. Tetrahedron Letters. 1994;35(10):1569–1572. doi: 10.1016/S0040-4039(00)76760-8.
• Kawagishi H., Shimada A., Hosokawa S., et al. Erinacines E, F, and G, stimulators of nerve growth factor (NGF)-synthesis, from the mycelia of Hericium erinaceum. Tetrahedron Letters. 1996;37(41):7399–7402. doi: 10.1016/0040-4039(96)01687-5.
• Kawagishi H., Simada A., Shizuki K., et al. Erinacine D, a stimulator of NGF-synthesis, from the mycelia of Hericium erinaceum. Heterocyclic Communications. 1996;2(1) doi: 10.1515/HC.1996.2.1.51.
• Lee E. W., Shizuki K., Hosokawa S., et al. Two novel diterpenoids, erinacines H and I from the mycelia of Hericium erinaceum. Bioscience, Biotechnology, and Biochemistry. 2000;64(11):2402–2405. doi: 10.1271/bbb.64.2402.
• Mori K., Inatomi S., Ouchi K., Azumi Y., Tuchida T. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytotherapy Research. 2009;23(3):367–372. doi: 10.1002/ptr.2634.
• Mori K., Obara Y., Hirota M., et al. Nerve growth factor-inducing activity of Hericium erinaceusin 1321N1 human astrocytoma cells. Biological & Pharmaceutical Bulletin. 2008;31(9):1727–1732. doi: 10.1248/bpb.31.1727.
• Chen C.-C., Tzeng T. T., Chen C. C., et al. Erinacine S, a rare sesterterpene from the mycelia of Hericium erinaceus. Journal of Natural Products. 2016;79(2):438–441. doi: 10.1021/acs.jnatprod.5b00474.
• Lu C.-C., Huang W. S., Lee K. F., et al. Inhibitory effect of erinacines A on the growth of DLD-1 colorectal cancer cells is induced by generation of reactive oxygen species and activation of p70S6K and p21. Journal of Functional Foods. 2016;21:474–484. doi: 10.1016/j.jff.2015.12.031.
• Tzeng T. T., Chen C. C., Chen C. C., et al. The cyanthin diterpenoid and sesterterpene constituents of Hericium erinaceusmycelium ameliorate Alzheimer’s disease-related pathologies in APP/PS1 transgenic mice. International Journal of Molecular Sciences. 2018;19(2) doi: 10.3390/ijms19020598.
• aito T., Aoki F., Hirai H., et al. Erinacine E as a kappa opioid receptor agonist and its new analogs from a basidiomycete, Hericium ramosum. The Journal of Antibiotics. 1998;51(11):983–990. doi: 10.7164/antibiotics.51.983.
• Lee K. F., Chen J. H., Teng C. C., et al. Protective effects of Hericium erinaceusmycelium and its isolated erinacine A against ischemia-injury-induced neuronal cell death via the inhibition of iNOS/p38 MAPK and nitrotyrosine. International Journal of Molecular Sciences. 2014;15(9):15073–15089. doi: 10.3390/ijms150915073.
• Ma B. J., Shen J. W., Yu H. Y., Ruan Y., Wu T. T., Zhao X. Hericenones and erinacines: stimulators of nerve growth factor (NGF) biosynthesis in Hericium erinaceus. Mycology. 2010;1(2):92–98. doi: 10.1080/21501201003735556.
• Krzyczkowski W., Malinowska E., Herold F. Erinacine A biosynthesis in submerged cultivation of Hericium erinaceum: quantification and improved cultivation. Engineering in Life Sciences. 2010;10(5):446–457. doi: 10.1002/elsc.201000084.
• Li I. C., Chen Y. L., Lee L. Y., et al. Evaluation of the toxicological safety of erinacine A-enriched Hericium erinaceusin a 28-day oral feeding study in Sprague-Dawley rats. Food and Chemical Toxicology. 2014;70:61–67. doi: 10.1016/j.fct.2014.04.040.
• Wolters N., Schembecker G., Merz J. Erinacine C: a novel approach to produce the secondary metabolite by submerged cultivation of Hericium erinaceus. Fungal Biology. 2015;119(12):1334–1344. doi: 10.1016/j.funbio.2015.10.005.
• Kuo H. C., Lu C. C., Shen C. H., et al. Hericium erinaceusmycelium and its isolated erinacine A protection from MPTP-induced neurotoxicity through the ER stress, triggering an apoptosis cascade. Journal of Translational Medicine. 2016;14(1):p. 78. doi: 10.1186/s12967-016-0831-y.
• Tsai-Teng T., Chin-Chu C., Li-Ya L., et al. Erinacine A-enriched Hericium erinaceusmycelium ameliorates Alzheimer’s disease-related pathologies in APPswe/PS1dE9 transgenic mice. Journal of Biomedical Science. 2016;23(1):p. 49. doi: 10.1186/s12929-016-0266-z.
• Chiu C.-H., Chyau C. C., Chen C. C., et al. Erinacine A-enriched Hericium erinaceusmycelium produces antidepressant-like effects through modulating BDNF/PI3K/Akt/GSK-3β signaling in mice. International Journal of Molecular Sciences. 2018;19(2):p. 341. doi: 10.3390/ijms19020341.
• Liu P. S., Chueh S. H., Chen C. C., Lee L. Y., Shiu L. Y. Lion’s mane medicinal mushroom, Hericium erinaceus(Agaricomycetes), modulates purinoceptor-coupled calcium signaling and murine nociceptive behavior. International Journal of Medicinal Mushrooms. 2017;19(6):499–507. doi: 10.1615/IntJMedMushrooms.v19.i6.20.
• Li I. C., Chen W. P., Chen Y. P., Lee L. Y., Tsai Y. T., Chen C. C. Acute and developmental toxicity assessment of erincine A-enriched Hericium erinaceusmycelia in Sprague-Dawley rats. Drug and Chemical Toxicology. 2018:1–6. doi: 10.1080/01480545.2017.1381110.
• Li I. C., Chen Y. L., Chen W. P., et al. Genotoxicity profile of erinacine A-enriched Hericium erinaceusToxicology Reports. 2014;1:1195–1201. doi: 10.1016/j.toxrep.2014.11.009.
• Chen C.-C. In the 14th Asian Consortium for the Conservation and Sustainable Use of Microbial Resources. National Taiwan University Hospital International Convention Center; 2017. Neurohealth manifestations rendered by erinacine-A enriched Hericium erinaceus